Seattle BioMed Founder Dr. Ken Stuart Named “Pioneer of Global Health Award” Winner

The award recognizes Dr. Stuart for his 35 years of research to eradicate the most devastating infectious diseases

SEATTLE--()--Seattle BioMed announced today its founder, Ken Stuart, Ph.D., has been presented with the Award for Impact by the Washington Global Health Alliance for his dedication to solving global health inequity and his commitment to bringing Washington State to the forefront of global health research.

“It has been a stimulating and gratifying experience to be a part of the global health research community. When I came to Seattle, the strong research was centered at the University of Washington and Seattle had somewhat of a localized feel,” said Dr. Stuart. “However, Seattle has become an epicenter of global health research through the work of many and their willingness to partner on our common goal of eradicating diseases that cause suffering and death for millions of people every year.”

Dr. Stuart founded Seattle BioMed more than 35 years ago with the vision to create a place where the brightest scientists could come together to develop innovative solutions to combat the world’s deadliest diseases. Today, the Institute has more than 200 employees solely focused on using modern technologies to research new drugs, vaccines and diagnostics that could help save the 14 million people who die from infectious diseases each year.

“Washington is home to hundreds of global health organizations and thousands of dedicated staff who work for health equity globally,” said Lisa Cohen, executive director of the Washington Global Health Alliance. “Our unique vantage point at WGHA allows us to see the people who’ve sacrificed higher paying jobs and public recognition to serve the world’s most vulnerable populations.”

The Award for Impact is one of three awards presented by the Washington Global Health Alliance as part of the 2014 Pioneers of Global Health Award series. The award winners were selected by a panel of global health experts with significant achievements in the development of diagnostics, drugs and vaccines for diseases like malaria, leprosy and tuberculosis. Each winner was selected because of their demonstrated desire to nurture and grow Washington’s collaborative global health community.

Dr. Stuart and the other winners will be honored at Washington Global Health Alliance’s annual event, the Pioneers of Global Health Awards Dinner, on October 9, 2014 at The Foundry.

To interview Ken Stuart, Ph.D., founder of Seattle BioMed, about this award and the research being conducted at Seattle BioMed, please contact James McIntosh at (206) 664-7822 or

About Seattle Biomedical Research Institute

Seattle BioMed is the largest independent, non-profit organization in the U.S. focused solely on infectious disease research. Our research is the foundation for new drugs, vaccines and diagnostics that benefit those who need our help most: the 14 million who will otherwise die each year from infectious diseases, including malaria, HIV/AIDS and tuberculosis. Founded in 1976, Seattle BioMed has more than 230 staff members. By partnering with key collaborators around the globe, we strive to make discoveries that will save lives sooner. For more information, visit

About the Washington Global Health Alliance

WGHA invites and activates every sector in our region to advance global health equity. They mobilize the dynamic global health sector to increase visibility and impact; advocate and educate lawmakers and business leaders about the importance of global health for the economy, international relationships and communities; and cultivate global health champions through innovative partnerships among traditional and unexpected organizations and people to expand impact. Learn more,


For Seattle BioMed
James McIntosh, 206-664-7822

Release Summary

Seattle BioMed announced today its founder, Ken Stuart, Ph.D., has been presented with the Award for Impact by the Washington Global Health Alliance.


For Seattle BioMed
James McIntosh, 206-664-7822